Capgras Syndrome (CS) is a delusional disorder, one of the Delusional Misidentification Syndromes (DMSs), in which the patient believes that an 'imposter' has taken the place of one of their loved ones. This, at instances, results in violence and aggression towards the supposed imposter. In this paper, the aim is to see to it that the syndrome receives the attention that it deserves and that the most recent advances in the research related to the syndrome are illustrated in a concise manner.
In this paper, we looked into the effect vitamin D supplementation has on depressive symptoms in different populations. We found that, despite the existence of clear evidence towards the hypothesis, the number of solid studies (meat-analyses) on the topic were rather few and did not cover all populations. With this article, we aim to make it perfectly clear that there exists a need for far more research on the topic. At least 1 study showed that vitamin D had no effect on depressive symptoms, which also necessitates further research. Furthermore, nations, such as the republic of the Sudan, need to establish 'normal' vitamin D levels in their populations. This is also meant to urge such researches into taking place.
Depression is an issue that faces humanity. It carries a high suicide rate as well as a very high morbidity rate. Combating depression is a deed that is bestowed upon metal health workers. A plethora of approaches to depression exist. Many of them being pharmaceutical in nature. The authors of this paper understand that these options are not always available to everyone and, ergo, decided to conduct a review article which explores the effects of exercise on depression. This research has showed that physical activity has significant positive effects on mental health in general (namely, depression and anxiety). This effect seems rather comparable to that of SSRIs. This is of importance as it illustrates the need for the immediate implementation of physical activity in their treatment modules to combat depression in our mental health institutes.
The Omicron variation (B.1.1.529) is a variation of SARS-CoV-2 (the infection that causes COVID-19) that was first countered to the World Health Organization (WHO) from South Africa on 24 November 2021. The omicron variation has transformations in both the RNA-subordinate RNA polymerase (RdRp), and the principle protease of SARS-CoV-2. Which focuses for antiviral medications like RdRp inhibitors (remdesivir and molnupiravir) and the primary protease inhibitor PF-07304814,5 which enlivens concern in regards to the diminished viability of these medications against omicron. WHO considers this variant as "Variant of Concern". This is due to the 33 mutations this variant has, and the fact that it was believed to spread more rapidly than previous variants as the number of cases were increasing. The antibodies, vaccines, and anti-virals that were previously used were proven to be effective towards the previous variants, but with the surprising number of mutations, how effective will it be towards the Omicron Variant? Our aim is to assess the efficacy of the Omicron Variant towards the antibodies, anti-virals, and vaccine. And to our surprise, while some of the well-known interventions were found to be effective towards the omicron variant, other studies proved otherwise. The fortunate thing is, despite its rapid mode of spread and diversities when it comes to intervention towards the wellknown medications previously used, it is associated with a speedy recovery rate. This study would like to clearly state that previous medications will likely work on the Omicron variant although not as effectively as it does on previous variants, while a few maintain high efficacy rates.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.